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Epidermal growth factor (EGF) acts as a paracrine and autocrine mediator of cell
proliferation and differentiation in various types of epithelial cells, such as sebocytes,
which produce the lipid-rich sebum to moisturize the skin. However, sebum lipids via
direct contact and by penetrating through the epidermis may have regulatory roles on
epidermal and dermal cells as well. As EGF receptor (EGFR) is expressed throughout the
proliferating and the lipid-producing layers of sebaceous glands (SGs) in healthy and
acne-involved skin, we investigated the effect of EGF on SZ95 sebocytes and how it may
alter the changes induced by palmitic acid (PA), a major sebum component with bioactive
roles. We found that EGF is not only a potent stimulator of sebocyte proliferation, but also
induces the secretion of interleukin (IL)6 and down-regulates the expression of genes
involved in steroid and retinoid metabolism. Importantly, when applied in combination with
PA, the PA-induced lipid accumulation was decreased and the cells secreted increased
IL6 levels. Functional clustering of the differentially regulated genes in SZ95 sebocytes
treated with EGF, PA or co-treated with EGF+PA further confirmed that EGF may be a
potent inducer of hyperproliferative/inflammatory pathways (IL1 signaling), an effect being
more pronounced in the presence of PA. However, while a group of inflammatory genes
was up-regulated significantly in EGF+PA co-treated sebocytes, PA treatment in the
absence of EGF, regulated genes only related to cell homeostasis. Meta-analysis of the
gene expression profiles of whole acne tissue samples and EGF- and EGF+PA -treated
SZ95 sebocytes showed that the EGF+PA co-activation of sebocytes may also have
implications in disease. Altogether, our results reveal that PA-induced lipid accumulation
and inflammation can be modulated by EGF in sebocytes, which also highlights the need
for system biological approaches to better understand sebaceous (immuno)biology.
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INTRODUCTION
Sebaceous glands (SGs) form together with the hair follicle the
pilosebaceous unit, with a primary function to produce sebum to
cover and lubricate the hair and the skin (1). Several studies,
however, suggested, that sebum lipids are not only moisturizers,
but may have additional biological functions (2–4). While PA
together with sapienic/palmitoleic (5) and oleic acids have
antimicrobial activities (6, 7), other lipids, such as squalene, are
known to be ultraviolet (UV) protective (8–10). Moreover, the
findings that i., SG-rich skin had a distinct immune milieu
compared to SG-poor skin (11) ii., a dynamic change both in
the amount and the ratio of sebum lipid fractions can be
observed in acne (12, 13), the primary disease associated with
the inflammation of the pilosebaceous unit affecting nearly 90%
of teenagers in the Western societies (14), and iii., sebaceous
lipids may penetrate through the epidermis (15, 16) or even
directly infiltrate the dermis when the pilosebaceous unit is
destroyed in severe acne, altogether suggest that sebocytes may
contribute to the dermal microenvironment with complex
regulatory functions on various cell types (17). In previous
own studies we showed that besides promoting T helper (Th)
17 cell differentiation via secreted proteins (18), sebocytes are
able to alter gene and protein expression through sebaceous
lipids in normal human keratinocytes and HaCaT cells (19),
while in human monocyte-derived macrophages each lipid had a
selective immunomodulatory effect (16). Supporting a key
position for PA in shaping the inflammatory environment, we
confirmed that PA is a more potent stimulator of interleukin (IL)
1 beta (IL1B) and tumor necrosis factor alpha (TNFA) cytokine
production than Propionibacterium acnes (P. acnes), the
commensal bacterium which has been associated with acne, in
in vitro differentiated monocyte-derived macrophages (16).
Moreover, PA treatment was shown to increase the secretion
of IL6 and IL8 in SZ95 sebocytes (20), cytokines that contribute
to inflammation in acne lesions (21).
Of the various factors known to affect sebocyte function (22),
such as hormones (23–30), neuropeptides (31–33) and Toll-like
receptor (TLR) ligands (34–36), EGF has a central role,
underpinned by the pioneering finding that it is essential to
maintain sebocytes in culture (37) and that its receptor (EGFR), a
member of the ErbB family of receptor tyrosine kinases (38) also
known as ERBB1 or HER1, had an increased density in the
peripheral layer of the glands, where proliferation dominates
over differentiation and lipid accumulation (39–42). Later studies
revealed that although EGF activation or overexpression in
mouse leads to enlarged SGs with hyperproliferating sebocytes
and increased lipogenesis (43, 44), in human sebocytes EGF
treatment resulted in an increased proliferation and reduced
lipogenesis (24). This was further supported by increased lipid
accumulation resulting through small interfering RNA (siRNA)-
mediated down-regulation of EGFR in SZ95 sebocytes (45).
Moreover, a possible interaction with testosterone also
suggested that at the time of puberty, EGF may lead to SG
hypertrophy and thus be involved in the development of acne
(46). Importantly, EGF as well as other EGFR ligands, such as
transforming growth factor alpha (TGFA), epigen, epiregulin,
amphiregulin, betacellulin, and heparin-binding EGF are found
in detectable amounts in the serum. More importantly, they can
also be produced by different skin cell types, such as
keratinocytes, fibroblasts, and sebocytes (47–49), suggesting
that EGFR activation in the skin may happen both in a
paracrine and an autocrine manner mediating signals of local
as well as of systemic origin.
While the postulate that EGF signaling in humans may be
crucial in balancing sebocytes between proliferation and
lipogenesis grants EGF a prime position in sebaceous biology,
there is still little data available on how it may alter the
inflammation signaling in sebocytes. The findings that EGFR
inhibitor-treated SZ95 sebocytes exhibit increased expression
levels of the inflammatory cytokines IL6, IL8 and TNFA, but
not of IL1 alpha (IL1A) (50) suggested that EGF is also involved
in the regulation of inflammation, but more extensive studies,
such as genome wide analyses, are needed to reveal the complex
changes in which EGF may be involved. Thus, in this study we
addressed the question of how EGF itself and in combination
with PA, a (patho)physiologically relevant lipid with both
differentiating as well as inflammatory properties (6, 16, 51,
52), could interact to modify phenotype, gene expression and
inflammation in human sebocytes.
MATERIALS AND METHODS
Cell Culture and Treatments
Immortalized human SZ95 sebocytes (53) were cultured at 37°C
in a humidified atmosphere containing 5% (v/v) CO2 in
Sebomed® Basal Medium (Cat. No.: F8205, Biochrom,
Cambridge, UK) supplemented with 10% fetal bovine serum
(FBS) (BioSera, Nuaillé, France), 1 mmol/L CaCl2, 500U/ml
penicillin, 0.5 mg/ml streptomycin (Sigma-Aldrich, St. Louis,
MO, USA) and 5 ng/ml EGF (dissolved in distilled water)
(Sigma-Aldrich). For experiments, cells were pre-conditioned
in EGF-free or in EGF-supplemented medium for 48 hours, then
passaged and re-plated keeping the conditions of EGF depletion
or supplementation. Re-plated sebocytes were treated with 150
µmol/L PA (Cat. no.: P0500, Sigma-Aldrich) dissolved in
ethanol:dimethyl sulfoxide (DMSO) in 1:1 ratio, heated at 37°C
for 10 minutes and mixed vigorously. The applied PA dose was
previously determined (Supplementary Figure 1). Untreated
cells were incubated with ethanol:DMSO in 1:1 ratio (vehicle
control). Cell treatment conditions were the following: CTR =
EGF-free vehicle control; EGF = EGF-supplemented and treated
with vehicle; PA = PA-treatment in absence of EGF; EGF+PA =
PA-treatment in presence of EGF. SZ95 sebocytes from three
subcultures were used for all experiments. An overview of our
experimental setup is shown in Figure 1B, where we indicate the
culturing conditions and the timepoints for sample collections.
Immunofluorescence Staining
Anonymized formalin-fixed and paraffin embedded (FFPE)
sections of human tissue samples of lesional skin from the
back of patients with papulopustular acne and from the back
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of healthy individuals were acquired from the archive of the
Department of Dermatology, University of Debrecen with the
approval of the Regional and Institutional Ethics Committee. 3
µm thick FFPE sections were deparaffinized and rehydrated. For
antigen retrieval, the slides were treated with Tris-
ethylenediaminetetraacetic acid (EDTA) buffer (10mM Tris
Base, 1mM EDTA solution, 0.05% Tween 20, pH 9.0) in
boiling pressure cooker (120°C) for 25 minutes and incubated
with 5% bovine serum albumin (BSA) dissolved in phosphate
buffered saline (PBS) to reduce non-specific binding. Tissue
sections were incubated with polyclonal rabbit anti-human
EGFR antibody (Cat. no.: sc-03; Santa Cruz, Dallas, TX, USA
diluted in 5% BSA-PBS at a 1:50 dilution) in a humidity chamber
at 4°C for overnight, while in the negative controls no primary
antibody was used. Goat anti-rabbit IgG Alexa Fluor 555
secondary antibody (Thermo Fisher Scientific, Waltham, MA,
USA) was used in accordance with the manufacturer’s
instructions. Slides were mounted with Vectashield mounting
medium with 4′,6-diamidino-2-phenylindole (DAPI) (Vector
Laboratories, Burlingame, California, USA) and images were
acquired with a Leica DM2000 LED microscope (Leica
Microsystems, Wetzlar, Germany) connected to an Olympus
DP74 camera (Shinjuku-ku, Tokyo, Japan).
Sulforhodamine B (SRB) Colorimetric
Proliferation Assay
To detect the proliferation rate, samples were collected at time of
re-plating at 48 hours, then at 24 and 72 hours after PA
treatment (marked as 48, 72 and 120 h in Figure 1C) as
described previously. After removing the culture medium, cells
were fixed with cold 10% trichloroacetic acid (TCA) overnight at
4°C and subsequently washed four times with tap water and
completely dried. 50 µl 0.04% SRB (dissolved in 1% acetic acid)
(Sigma-Aldrich) was added to each well and plates were
incubated at room temperature for 1 hour. To remove
unbound dye, plates were rinsed four times with 1% acetic
acid. To solubilize the protein-bound dye, 50 µl of 10 mmol/L
Tris base solution (pH 10.5) was added to each well and plates
were shaken on an orbital shaker for 10 minutes. The optical
density (OD) was measured at 510 nm in an Epoch microplate
spectrophotometer (BioTek, Winooski, VT, USA). SRB
absorbance value of the 48 hours CTR sample was taken for
100% and was used for normalization in all measurements. SZ95
sebocytes from three subcultures were used, samples were
measured in five replicates from three independent experiments.
Lipid Staining
To detect intracellular lipids, SZ95 sebocytes were cultured and
treated with PA as described above for 72 hours. Cells were then
washed with PBS and stained with AdipoRed (Lonza, Basel,
Switzerland) according to the manufacturer’s instructions.
Neutral lipids were detected with excitation at 485 nm and
emission at 565 nm, while polar lipids with excitation at 540
nm and emission at 620 nm using a Tecan Spark 20M
fluorometer (Tecan Trading AG, Männedorf, Switzerland).
Arbitrary fluorescent unit (AFU) score ratios of neutral lipids
and of polar lipids are presented. SZ95 sebocytes from three
subcultures were used, samples were measured in five replicates
in three independent experiments.
Enzyme-Linked Immunosorbent
Assay (ELISA)
To measure the secretion of IL6 protein, SZ95 sebocytes were
cultured as described above. Supernatants were collected at 24
hours after PA treatment, aliquoted and stored at -20°C until
further analyses. IL6 protein levels were measured using ELISA
Duoset (Cat. No.: DY206, R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s instructions. 3,3′,5,5′-
Tetramethylbenzidine (TMB) (Sigma-Aldrich) chromogenic
substrate was used as visualizing reagent and the reaction was
stopped with 1mol/L H2SO4. Optical density was measured
in an Epoch microplate spectrophotometer (BioTek) at
450 nm wavelength. SZ95 sebocytes from three subcultures
were used, samples were measured in duplicates in five
independent experiments.
Determination of mRNA Levels
SZ95 sebocytes were cultured for 24 hours after PA treatment, as
previously described. Total RNA was isolated using TRI Reagent
(MRC, Cincinnati, OH, USA) according to the manufacturer’s
protocol. Total RNA sample quality was checked on Agilent
BioAnalyzer using Eukaryotic Total RNA Nano Kit according to
manufacturer’s protocol (Agilent, St. Laurent, Quebec, Canada).
Samples with RNA integrity number (RIN) value >7 were
accepted for library preparation process. RNA-Seq libraries
were prepared from total RNA using Ultra II RNA Sample
Prep kit (New England BioLabs, Évry-Courcouronnes, France)
according to the manufacturer’s protocol. Briefly, poly-A RNAs
were captured by oligo-dT conjugated magnetic beads, then the
mRNAs were eluted and fragmented at 94°C. First strand cDNA
was generated by random priming reverse transcription and after
second strand synthesis step double stranded cDNA was
generated. After repairing ends, A-tailing and adapter ligation
steps adapter ligated fragments were amplified in enrichment
PCR and finally sequencing libraries were generated. Sequencing
run was executed on Illumina NextSeq500 instrument (Illumina,
San Diego, CA) using single-end 75 cycles sequencing.
RNA-Seq Data Analysis
Raw sequencing data (fastq) was aligned to human reference
genome version GRCh38 using HISAT2 algorithm and BAM
files were generated. Downstream analysis was performed using
StrandNGS software (version 2.8, build 230243; Strand Life
Sciences, Bangalore, India). BAM files were imported into the
software, DESeq algorithm was used for normalization and
normalized expression data were used for statistical analysis.
Biological process, Reactome and KEGG pathway analyses were
performed using the Cytoscape 3.7.1 software with the ClueGO
v2.5.4 plug-in (54). Results are expressed as average mean values
of three samples from subcultures of SZ95 sebocytes. Heat maps
displaying the replicates separately are provided as a supplement
to support the heat maps in the figures that show mean average
values (Supplementary Figures 2-11). Principal component
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analysis (PCA) shows the possible batch-to-batch variation
in the dataset (Supplementary Figure 12). Gene expression
data of differentially up- and down-regulated genes were
filtered with 2-fold change. RNA-Seq data are available in




All data are presented as mean ± SEM. The normality of the
population was determined using the Shapiro-Wilk test. One-
way ANOVA and Tukey post-hoc tests were used for the analysis
of RNA-seq data. For cell proliferation experiments, two-way
ANOVA supplemented with Tukey post-hoc test was used. Lipid
assay and ELISA experiments were analyzed by Kruskal-Wallis
test and Dunn post-hoc test. Differences by p<0.05 values were
considered statistically significant.
RESULTS
EGFR Is Expressed in the Basal Layer as
Well as in the Lipid Producing Cells of
Sebaceous Glands
To provide a biological relevance for our hypothesis that EGF
and lipids may orchestrate the functions of sebocytes both under
physiological as well as pathological conditions, we first
performed immunofluorescence staining with a specific EGFR
antibody in human skin samples of healthy individuals (normal
skin) and of patients with papulopustular acne. We confirmed
the results of Nanney et al. (40) that the expression of EGFR is
not restricted to the basal proliferating layer (39) but, although
with a weaker signal, is also detected in the lipid-producing
sebocytes of healthy as well as acne-involved skin (Figure 1A).
EGF Modulates Proliferation, the PA-
Induced Lipogenesis and Inflammation
in SZ95 Sebocytes
To assess the interaction of EGF with lipids in regulating
sebocyte functions, such as proliferation, lipogenesis and
inflammation (Figure 1B), we used the human sebaceous
gland cell line SZ95, the most accepted in vitro human
sebocyte model (53). In order to choose a sebum lipid for our
studies, which has bio-active properties that may be linked to
pathological conditions such as acne, we performed ELISA
measurements using supernatants from SZ95 sebocytes treated
with sebum lipids such as PA, linoleic acid (LA), oleic acid (OA)
and arachidonic acid (AA), which revealed that only PA was a
potent inducer of IL6 secretion, a marker for acne-associated
sebocyte inflammation (21) (Supplementary Figure 1).
SZ95 sebocytes cultured in the presence of EGF exhibited a
significantly higher proliferation at 72 and 120 hours compared
to cells cultured in the absence of EGF. Importantly, when PA
was also added to the culture at the 48 hours timepoint, as
described in the Materials and Methods, a tendentious decrease
was found in EGF induced proliferation at the 72 and 120 hours
timepoints (Figure 1C).
Lipid amount in EGF-treated, PA-treated and EGF+PA co-
treated sebocytes was determined by neutral/polar lipid ratio 72
hours after PA treatment. Lipid measurements revealed that EGF
treatment together with PA led to a decreased amount of
intracellular lipids when compared to the lipids detected under
PA treatment only (Figure 1D).
Measuring IL6 protein levels by ELISA from cell
supernatants, EGF was able to increase IL6 secretion from
SZ95 sebocytes, which was more pronounced under EGF+PA
co-treatment. Interestingly, in the absence of EGF, PA treatment
only slightly modified IL6 levels (Figure 1E).
These results confirmed previous findings that EGF promoted
the proliferation of human sebocytes (42, 55), while the presence
of a ubiquitously present lipid, such as PA, induced lipogenesis.
Our novel findings that EGF was an inducer of IL6 in sebocytes
and that the inflammatory effect of PA was dependent on EGF
have set the basis for our genome-wide gene expression studies.
EGF Promotes IL1 Signaling in
SZ95 Sebocytes
To identify the EGF-induced transcriptional changes in sebocytes,
we compared the gene expression profile of SZ95 sebocytes cultured
with or without EGF supplementation in the medium for 72 hours
as described in the Materials and Methods. Functional clustering of
the 218 down-regulated transcripts resulted in clusters related to
steroid, retinoid and lipid metabolism, and to epidermal
differentiation (Figure 2A), while the up-regulated 81 transcripts
were most prominent in the gene clusters involved in IL1 signaling,
chemotaxis and blood vessel development (Figure 2B).
Gene Expression Profile of PA and EGF
Co-Treated Sebocytes Is Distinct From the
Profile of Cells Treated With Either PA or
EGF Alone
To get a deeper insight into how the expression of genes regulated
by PA is changed in the presence of EGF, we compared the gene
expression profiles of EGF-treated, PA-treated and EGF+PA co-
treated SZ95 sebocytes. Generating a heat map with the genes
reaching the level of significance at the measured timepoint, 24
hours after PA treatment, showed that while some genes were only
regulated in the PA-treated but not in the EGF+PA co-treated
sebocytes, a group of genes, which were up-regulated by EGF were
further induced when PA was added in combination with EGF.
Interestingly, a set of genes was also detected, which were
significantly regulated only in the co-treated sebocytes (Figure 3).
PA Treatment in the Absence of
EGF Induces Changes Related to
Cell Homeostasis
Using Venn diagrams to visualize the genes differentially down- and
up-regulated in response to PA, 80 transcripts were found to be
down- (Figure 4A) and 135 transcripts to be up-regulated (Figure
4B) in the PA-treated SZ95 sebocytes when compared to control.
While of the 80 down-regulated transcripts only 10, of the 135 up-
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FIGURE 1 | EGFR is expressed in sebaceous glands of healthy and acne involved skin and EGF modulates proliferation, lipid production and inflammation in
SZ95 sebocytes. (A) FFPE tissue samples were stained with an anti-EGFR rabbit polyclonal antibody as described in Materials and Methods. Note that similar
staining intensities are observed in normal and in papulopustular acne skin samples, localizing to both the proliferating as well as the lipid producing layers of
sebaceous glands. Negative controls were processed without using primary antibody. Slides were mounted with Vectashield mounting medium with DAPI. Scale
bar = 200 µm. (B) SZ95 sebocytes were cultured in the presence or absence of EGF. At 48 hours 150 µmol/L PA or vehicle was added to the medium and
SZ95 sebocytes were cultured for further 24 and 72 hours (marked as 72 h and 120 h). Samples were collected, processed, and measured as described in
Materials and Methods at the relevant timepoints. (C) Sulforhodamine B assay was used as described in Materials and Methods to detect the rate of
proliferating sebocytes cultured in the presence or absence of EGF for 48, 72 and 120 hours and treated with 150 µmol/L PA, at 48 hours timepoint. EGF
significantly induced cell proliferation at 72 and 120 hours, whereas proliferation was tendentiously decreased after co-treatment with PA. Samples from three
subcultures of SZ95 sebocytes were used for the experiments and three independent measurements were performed. SRB data were normalized to the
absorbance of the 48 hours CTR samples which was taken for 100%. Two-way ANOVA and Tukey post-hoc tests were used in the analysis of SRB data. All
data are presented as mean ± SEM. *p < 0.5, ***p < 0.005. (D) AdipoRed staining used to detect polar and neutral lipids as described in Materials and Methods
in SZ95 sebocytes cultured in the presence or absence of EGF and treated with 150 µmol/L PA for 72 hours showed that EGF decreased PA-induced
lipogenesis. Amount of neutral lipids are normalized with polar lipids, which correlate with cell numbers. Results are expressed as average of three independent
measurements using samples from three subcultures of SZ95 sebocytes. Kruskal-Wallis test and Dunn post-hoc tests were used in the analysis of data. All data
are presented as mean ± SEM. *p < 0.05, ***p < 0.005. (E) Supernatants from SZ95 sebocytes cultured in the presence or absence of EGF and treated with
150 µmol/L PA for 24 hours were used to determine the levels of IL6 by ELISA as described in Materials and Methods. Results are expressed as average of
protein concentrations (pg/mL) of five independent measurements using samples from three subcultures of SZ95 sebocytes. Kruskal-Wallis test and Dunn post-
hoc tests were used in the analysis of ELISA data. All data are presented as mean ± SEM. *p < 0.05, ***p < 0.005.
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regulated ones 113 were found to be regulated exclusively in PA
treated sebocytes cultured without EGF. After performing
clustering, the down-regulated 10 transcripts, could not be
grouped into any with functional relevance. However, the 113
transcripts up-regulated only in the PA treated sebocytes cultured
without EGF, formed clusters related to cell homeostasis, such as cell
adhesion, glucose metabolic processes and hormone activity,
synaptic formation, regulation of secretion and fatty acid
responses (Figure 4C), in which the increased expression of
forkhead box A2 (FOXA2), complexin 2 (CPLX2), RAR related
A
B
FIGURE 2 | EGF-induced transcriptional changes in SZ95 sebocytes. SZ95 sebocytes were cultured in the presence or absence of EGF. Samples for RNA-seq
measurements were harvested at 72 hours of culturing, processed and measured as described in Materials and Methods. (A) The 218 transcripts that were significantly
down-regulated in SZ95 sebocytes cultured in the presence of EGF (EGF) when compared to cells cultured in the absence of EGF (CTR) were clustered into the groups of
steroid hormone biosynthesis, lipid metabolic process, skin development and response to wounding. Heat map display of the down-regulated transcripts contributing to the
clusters. Differentially expressed genes were normalized to control and results are expressed as average mean of three samples from subcultures of SZ95 sebocytes. Color
intensities reflect the ratios of signal intensities. (B) The 81 transcripts that were significantly up-regulated in SZ95 sebocytes cultured in the presence of EGF (EGF) when
compared to cells cultured in the absence of EGF (CTR), were clustered into the groups of IL1 signaling, blood vessel development and inflammatory responses. Heat map
display of the up-regulated transcripts contributing to the clusters. Differentially expressed genes were normalized to control and results are expressed as average mean of
three samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown.
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orphan receptor C (RORC), phosphoinositide-3-kinase regulatory
subunit 6 (PIK3R6), pancreatic and duodenal homeobox 1 (PDX1)
and adiponectin (ADIPOQ) genes, as displayed in the heat map,
could have a potential role (Figure 4D).
PA Treatment Gains Its Potential to
Regulate Extracellular Matrix Formation,
Lipid Metabolism and Inflammation
Related Genes in Sebocytes in the
Presence of EGF
To define the EGF-dependent effects of PA at the level of gene
expression regulation, we first addressed the 300 down-regulated
transcripts, which were only detected in the EGF+PA co-treated
SZ95 sebocytes (Figure 5A). Functional clustering revealed that
EGF and PA when applied together, decreased the expression of
genes involved in modulating the extracellular matrix (Figure
5B). The heat map displaying the transcripts which are forming
the functional clusters, shows that mostly genes encoding matrix
metalloproteinases and collagens are suppressed as a result of the
co-treatment (Figure 5C).
The Venn diagram, with the 169 transcripts that were
significantly up-regulated in the EGF+PA co-treated
sebocytes showed that in the case of 93 genes a significant
regulation was only detected in the EGF+PA co-treated
sebocytes (Figure 5D). Analysis of the up-regulated
transcripts revealed that the most significant changes were
related to genes involved in lipid responses, regulation of
apoptotic processes, cytokine signaling and inflammatory
responses (Figure 5E). Interestingly, displaying the
transcripts which contributed to the defined functional
clusters in a heat map, revealed that many had a tendency
of up-regulation already by EGF and/or by PA treatment, but
reached the level of significance only when sebocytes were co-
treated with EGF+PA (Figure 5F).
PA Treatment Augments the Inflammatory
Effects of EGF at the Level of
Gene Expression
Next, we aimed to analyze the expression of the genes which were
significantly regulated both in EGF-treated, PA-treated and in
the EGF+PA co-treated sebocytes.
When analyzing the overlapping 199 down-regulated
transcripts displayed in the Venn diagram (Figure 6A), the
same clusters, such as steroid, retinoid and lipid metabolism,
and epidermal proliferation were obtained as from assessing the
EGF-induced transcriptional changes (Figure 6B), but with a
greater number of contributing transcripts (Figure 6C).
Functional clustering of the 66 up-regulated transcripts
(Figure 6D), provided clusters related to immune functions,
such as cytokine regulation and chemotaxis, regulation of
adaptive immune response and IL1 signaling (Figure 6E).
Importantly, the heat map presenting the relevant genes which
contributed to the clusters further confirmed our previous
findings that PA and EGF together might interact in shaping
sebocyte functions and augment their inflammatory properties at
the level of gene expression regulation (Figure 6F).
FIGURE 3 | Gene expression profile of EGF-treated, PA-treated and EGF+PA-co-treated sebocytes. Differentially expressed genes shown as a heat map in SZ95
sebocytes treated with PA for 24 hours in the absence (PA) or presence of EGF (EGF+PA), and in SZ95 sebocytes cultured in the presence of EGF (EGF) when
compared to cells cultured in the absence of EGF (CTR) as observed by our RNA-seq analysis. Differentially expressed genes were normalized to control and results
are expressed as average mean of three samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown. Venn diagram
visualizes the number of genes which are significantly regulated between treatment conditions (EGF (green), EGF+PA (purple) and PA (pink) treated SZ95 sebocytes)
24 hours after PA treatment when compared to SZ95 sebocytes cultured in the absence of EGF (CTR) as observed by our RNA-seq analysis.
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Meta-Analysis of Gene Expression Profiles
of Acne Samples, EGF-Treated and
EGF+PA- Co-Treated SZ95 Sebocytes
Suggests That PA Together With EGF May
Play a Role in Inducing Inflammation
Under (Patho)physiological Conditions
To provide further biological relevance for our studies, a meta-
analysis was performed using available gene expression data of
acne whole tissue samples (56).
Using a Venn diagram to visualize the down-regulated
transcripts in acne samples compared to healthy ones and in
the EGF-treated and EGF+PA-co-treated SZ95 sebocytes
compared to untreated controls, a possible contribution of 34
significantly altered transcripts from EGF-treated and an
additional 41 transcripts from the EGF+PA-co-treated
sebocytes to acne pathogenesis could be detected (Figure 7A),
with a possible role in the differentiation and lipid metabolism of
sebocytes (Figure 7B). The heat map revealed that the involved
A B
DC
FIGURE 4 | Transcriptional changes induced by PA exclusively when SZ95 sebocytes are cultured without EGF. (A) Venn diagram visualizing the number of genes
which are significantly down-regulated between treatment conditions (EGF (green), EGF+PA (purple) and PA (pink) treated SZ95 sebocytes) 24 hours after PA
treatment when compared to SZ95 sebocytes cultured in the absence of EGF (CTR) as observed by our RNA-seq analysis. Note that the 10 transcripts which were
down-regulated only in the PA treated sebocytes could not be grouped into any functional cluster. (B) Venn diagram visualizing the number of transcripts which are
significantly up-regulated between treatment conditions (EGF (green), EGF+PA (purple) and PA (pink) treated SZ95 sebocytes) 24 hours after PA treatment when
compared to SZ95 sebocytes cultured in the absence of EGF (CTR) as observed by our RNA-seq analysis, revealed that 113 transcripts were specific for the PA
treatment. (C) The 113 transcripts that were up-regulated only in PA (PA vs. CTR) but not in EGF+PA co-treated SZ95 sebocytes were functionally categorized into
groups related to cell homeostasis. (D) Heat map display of the transcripts significantly up-regulated only in PA treated (PA), but not in EGF+PA co-treated (EGF+PA)
SZ95 sebocytes that contributed to the clusters. Differentially expressed genes were normalized to control and results are expressed as average mean of three
samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown.
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genes had the highest change in their expression levels when
sebocytes were co-treated with EGF+PA (Figure 7C).
When assessing the up-regulated transcripts a possible
contribution of 15 significantly up-regulated transcripts from
EGF-treated and an additional 21 transcripts from the EGF+PA-
co-treated sebocytes could be detected (Figure 7D). Clustering
the identified genes, showed that in the EGF+PA-co-treated
sebocytes not only IL1 but also IL17 signaling, characteristic
both for SG-rich healthy skin and for acne-involved skin, was
induced (Figure 7E). Generation of a heat map with the
transcripts contributing to the clusters, confirmed that EGF
when appl ied with PA may have more prominent
inflammatory effects, as revealed by the enhanced expression of
IL1 signaling related genes, compared with conditions where
sebocytes were only treated with EGF or PA. Interestingly and in
line with our previous findings, genes such as C-X-C motif
chemokine ligand 8 (CXCL8) and prostaglandin-endoperoxidase
synthase 2 (PTGS2) were only induced significantly when
sebocytes were co-treated with EGF+PA (Figure 7F).
Importantly, despite the low number of the overlapping genes,
the majority of the identified transcripts (such as CXCL8, IL1B,
IL6, NLR family pyrin domain containing 3 [NLRP3] and PTGS2)
are also pivotal in acne pathogenesis, suggesting that EGF- and
PA-induced signaling in sebocytes may have a (patho)
physiological relevance.
DISCUSSION
Using an unbiased system-based approach of RNA-sequencing
of SZ95 sebocytes, the best characterized sebaceous in vitro
model, to reveal the effects of EGF, PA or their combination,
we provide evidence that EGF and PAmay contribute together to
sebocyte functions both under physiological conditions as well as
in disease settings, such as acne.
Sebocyte inflammatory signaling, marked by increased
expression of cytokines IL6, IL8, IL1B and lipid-metabolizing
enzymes, such as 5-lipoxygenase (5LOX) or cyclooxygenase 2
(COX2 or PTGS2), was shown to be increased in acne (21, 57),
however prominent immune and barrier differences were
observed already in the healthy skin rich in SGs compared to
that with less SGs (11, 58). The latter finding, therefore, raised
the possibility that even under physiological conditions, SG may
determine basic immune features and/or contribute to the
altered microbiome directly with their lipids and proteins (59),
where first explanation of the mechanisms have currently been
provided (17, 58). Our findings that EGF alone and in
combination with PA induces the expression of immune-
related genes and pathways in sebocytes, add further details
and provide an example on how physiological signals may
facilitate SGs to become immunologically active. However,
limitations might arise from our in vitro settings such as using
a single cell line, the number of the analyzed replicates and the
possibility that sebocytes with their active enzymatic machinery,
could modify PA and, therefore, the produced derivatives may
contribute to further processes (13).
Important result of our studies was the finding that EGF alone
was able to promote IL1 signaling at the level of gene expression,
which complemented previous studies using cetuximab - an
EGFR inhibitor - in SZ95 sebocytes, where inhibition of EGF
signaling increased the expression levels of inflammatory
cytokines IL6, IL8 and TNFA, but not of IL1A. Since IL1A is a
key cytokine to modulate not only inflammation, but also
fol l icular kerat inocyte prol i ferat ion and abnormal
differentiation, leading to comedogenesis, the initial step in the
development of acne, which is missing in cetuximab-induced
papulopustular eruptions (50), our results provide interesting
start points for further studies to assess the role of EGF in the
pathogenesis of diseases with follicular obstruction. Interestingly,
the findings that in the EGF-treated sebocytes, IL6 was expressed
at higher mRNA and secreted protein levels when compared to
the cells cultured in the absence of EGF, suggests that the
inhibition and the absence of EGF signaling should be
addressed separately. Moreover, studies on sebocytes should be
performed and evaluated also with a care on the presence of EGF
in the culture medium. As revealed by our results, the
inflammatory properties and the proliferation of the cells are
already altered at the level of gene expression when sebocytes are
cultured with EGF, just as the lipid profile and the metabolism of
retinoids and steroids may be affected as well (24, 26, 60).
One of the most interesting findings is that PA - a major
component of sebum ubiquitously synthetized and secreted from
sebocytes - is a regulator of sebocyte homeostasis, and its effect is
more pronounced in the presence of EGF, since it suggests a so far
uncharacterized role for sebum in contributing to SG homeostasis.
Furthermore, our results suggests that SGs could even contribute to
the integrity of the entire pilosebaceous unit. Although their
possible effect on vascularization has already been proposed with
FIGURE 5 | Transcriptional changes induced by PA exclusively when SZ95 sebocytes are cultured in the presence of EGF. (A) Venn diagram visualizing that 300
transcripts were significantly down-regulated only in the condition when both EGF and PA was present in the culturing medium of the SZ95 sebocytes as observed
by our RNA-seq analysis. (B) The 300 transcripts that were down-regulated only in SZ95 sebocytes cultured in the presence of both EGF and PA were functionally
categorized into groups of extracellular matrix organization, collagen and elastic fiber formation. (C) Heat map display of the ones out of the 300 transcripts with
significant down-regulation only in the EGF+PA co-treated sebocytes which were forming clusters. Differentially expressed genes were normalized to control and
results are expressed as average mean of three samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown.
(D) Venn diagram visualizing that 93 transcripts were significantly up-regulated only when both EGF and PA was present in the culturing medium of the SZ95
sebocytes as observed by our RNA-seq analysis. (E) Functional clustering of the 93 transcripts showing significant up-regulation only in SZ95 sebocytes cultured in
the presence of both EGF and PA confirmed that PA together with EGF had a complex regulation on genes involved in both lipid metabolism and inflammation.
(F) Heat map display of the cluster forming 93 differentially expressed transcripts that showed a significant up-regulation only in the EGF+PA co-treated SZ95
sebocytes. Differentially expressed genes were normalized to control and results are expressed as average mean of three samples from subcultures of SZ95
sebocytes. Color intensities reflect the ratios of signal intensities as shown. Note that many of the transcripts had a tendency of up-regulation by EGF and/or by PA
treatment, but the co-treatment was necessary to reach the level of significance.
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FIGURE 6 | Combined actions of PA and EGF on the gene expression profile of SZ95 sebocytes. (A) Venn diagram showing the 199 transcripts which were
significantly down-regulated when EGF or EGF+PA was used in combination to treat SZ95 sebocytes, as observed by our RNA-seq analysis. (B) Functional
clustering of the 199 transcripts showing significant down-regulation in the EGF and the EGF+PA co-treated SZ95 sebocytes revealed that the most significant
changes were related to genes involved in hormone and lipid metabolic processes of sebocytes. (C) Heat map display of the transcripts which were clustered out of
the 199 transcripts with significant down-regulation both in the EGF and the EGF+PA co-treated SZ95 sebocytes. Differentially expressed genes were normalized to
control and results are expressed as average mean of three samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities.
(D) Venn diagram showing the 66 transcripts which were significantly up-regulated when EGF or EGF+PA was used in combination to treat SZ95 sebocytes, as
observed by our RNA-seq analysis. (E) Functional clustering of the 66 genes displayed in the Venn diagram defined that EGF alone and in combination with PA
regulated immune features of SZ95 sebocytes, notably IL1 signaling. (F) Heat map display of the genes which were clustered out of the 66 differentially expressed
transcripts. Differentially expressed genes were normalized to control and results are expressed as average mean of three samples from subcultures of SZ95
sebocytes. Color intensities reflect the ratios of signal intensities. Note the interaction between EGF and PA to regulate the expression of the genes which were
already significantly regulated either by EGF or by PA.
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FIGURE 7 | Meta-analysis using gene expression profiles from acne samples, EGF-treated and EGF+PA- co-treated SZ95 sebocytes. (A) Venn diagram visualizing
the number of transcripts that were significantly down-regulated in acne whole tissue samples from the available gene expression profiles of Kelhala HL et al. (NCBI
GEO accession number: GSE5379) (56) and in EGF and EGF+PA co-treated SZ95 sebocytes. (B) Functional clustering of the 75 (41 + 34) transcripts that were
significantly down-regulated both in the EGF+PA co-treated SZ95 sebocytes and in acne whole tissue samples (56) revealed that the most significant changes were
related to genes involved in skin development and fatty acid metabolic process. (C) Heat map display of the genes which were clustered out of the 75 significantly
down-regulated transcripts. Differentially expressed genes were normalized to control and results are expressed as average mean of three samples from subcultures
of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown. (D) Venn diagram visualizing the number of transcripts that were significantly up-
regulated in acne whole tissue samples from the available gene expression profiles of Kelhala et al. (56) and in EGF and EGF+PA co-treated SZ95 sebocytes.
(E) Functional clustering of the 36 transcripts that were significantly up-regulated both in the EGF and EGF+PA co-treated SZ95 sebocytes and in acne whole tissue
samples (56) revealed that EGF in combination with PA may contribute to the (patho)physiologically relevant IL1 and IL17 signaling in SZ95 sebocytes. (F) Fold
change value based hierarchical clustering of the cluster forming genes, showing their expression levels in the PA, EGF and EGF+PA co-treated SZ95 sebocytes,
that are significantly up-regulated in the EGF and EGF+PA co-treated SZ95 sebocytes when compared to untreated cells at 24 hours and in the available gene
expression profiles of acne whole tissue samples (56). Differentially expressed genes were normalized to control and results are expressed as average mean of three
samples from subcultures of SZ95 sebocytes. Color intensities reflect the ratios of signal intensities as shown. Note that the majority of the identified genes, showing
a prominent expression in SZ95 sebocytes treated with PA in combination with EGF (such as CXCL8, IL1A, IL1B, IL6, NLRP3 and PTGS2), are pivotal in the
pathogenesis of acne.
Törőcsik et al. EGF Dependent Palmitic Acid-Induced Inflammation
Frontiers in Immunology | www.frontiersin.org May 2021 | Volume 12 | Article 60001712
the detection of vascular endothelial growth factor (VEGF) in SGs
(61), SGs may also change their production of connective tissue
elements and of enzymes involved in modifying the extracellular
matrix (62), which findings definitely call for further studies.
Our further results that in the presence of EGF, PA could also
have an immunologically active role, and the results that
induction of a group of genes was only reaching the level of
significance when both PA and EGF were present, suggest that
these agents could promote each other and therefore both EGF
and PA (regarding levels and signaling pathways) could be of
therapeutic relevance. Moreover, the prominent induction of
genes , such as PTGS2, CXCL8, IL6 , IL1B, matr ix
metalloproteinase 1 (MMP1) and NLRP3, even raised the
possibility that EGF and PA may be involved in the
pathogenesis of acne. Based on these findings it is reasonable
to speculate that the altered ratio of sebum components (2) and
the increased amount of sebum - and with that the increased PA
levels - might have regulatory and inflammatory roles in the
manifestation of this disease, however only when other factors,
that are yet to be identified in more details, are present (63).
Altogether our results confirmed previous findings that EGF
is a stimulator of sebocyte proliferation, and provided new results
supporting its inflammatory effect by IL1 pathway induction. We
also extended our knowledge on the role of PA in sebocytes and
revealed that PA is primarily involved in cell homeostasis, but
can become a potential inflammatory agent in the presence of
EGF. The findings that sebocytes treated with both EGF and PA,
while conserving their enhanced proliferation and increased
lipogenesis, also acquired a prominent inflammatory gene
expression profi le may have further implications in
understanding acne development (Figure 8). Our results are of
great importance also in regards of promoting a system-based
approach in basic research, pointing on the need to also explore
combined effects of relevant stimuli, which may bring us closer in
understanding the complexity of sebaceous immunobiology and
acne development.
FIGURE 8 | Interaction between EGF and PA to modulate cell proliferation, lipogenesis and inflammatory responses in sebocytes. Based on our results, EGF
induces proliferation and inflammatory pathways in sebocytes while down regulates the expression of genes involved in steroid and retinoid metabolism. PA
treatment regulates lipogenesis and induces genes related to cell homeostasis in human sebocytes. When both EGF and PA is present, sebocytes exert an
increased proliferation, lipogenesis and a prominent up-regulation of inflammatory genes, while genes involved in the extracellular matrix formation are down-
regulated, which may have (patho)physiological relevance in shaping the inflammatory dermal environment.
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Zouboulis and Kovaćs. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
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